The University of Michigan
Human Breast Cancer Cell Lines

The "SUM" human breast cancer cell line home page.

Special News

Asterand, Inc., the Detroit-based supplier of human tissue products and services, announces the distribution of eleven breast cancer cell lines, derived at the University of Michigan. The University has agreed to license the marketing of the breast cancer cell lines, known as the SUM lines, through Asterand in an effort to provide an exceptional tool to a broad base of researchers studying the disease. There are an estimated 1.2 million new diagnoses worldwide of breast cancer each year. The cell lines can be used to study all aspects of breast cancer biology, from new drug target identification to cell signaling to effects of novel drugs on cellular proliferation.

Place an order, learn more here

This page is a part of the U-M Health System. The information presented is not a tool for self-diagnosis or a substitute for professional care. Please read the disclaimer and the privacy statement for more information.

copyright 2006 U-M Comprehensive Cancer Center